Cargando…

Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes

BACKGROUND: Drug metabolizing enzymes (DMEs) exhibit dramatic inter- and intra-individual variability in expression and activity. However, the mechanisms determining this variability have not been fully elucidated. The aim of this study was to evaluate the biological significance of DNA methylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Habano, Wataru, Kawamura, Kohei, Iizuka, Natsuki, Terashima, Jun, Sugai, Tamotsu, Ozawa, Shogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587720/
https://www.ncbi.nlm.nih.gov/pubmed/26421064
http://dx.doi.org/10.1186/s13148-015-0136-7
_version_ 1782392501809709056
author Habano, Wataru
Kawamura, Kohei
Iizuka, Natsuki
Terashima, Jun
Sugai, Tamotsu
Ozawa, Shogo
author_facet Habano, Wataru
Kawamura, Kohei
Iizuka, Natsuki
Terashima, Jun
Sugai, Tamotsu
Ozawa, Shogo
author_sort Habano, Wataru
collection PubMed
description BACKGROUND: Drug metabolizing enzymes (DMEs) exhibit dramatic inter- and intra-individual variability in expression and activity. However, the mechanisms determining this variability have not been fully elucidated. The aim of this study was to evaluate the biological significance of DNA methylation in the regulation of DME genes by genome-wide integrative analysis. RESULTS: DNA methylation and mRNA expression profiles of human tissues and hepatoma cells were examined by microarrays. The data were combined with GEO datasets of liver tissues, and integrative analysis was performed on selected DME genes. Detailed DNA methylation statuses at individual CpG sites were evaluated by DNA methylation mapping. From analysis of 20 liver tissues, highly variable DNA methylation was observed in 37 DME genes, 7 of which showed significant inverse correlations between DNA methylation and mRNA expression. In hepatoma cells, treatment with a demethylating agent resulted in upregulation of 5 DME genes, which could be explained by DNA methylation status. Interestingly, some DMEs were suggested to act as tumor-suppressor or housekeeper based on their unique DNA methylation features. Moreover, tissue-specific and age-dependent expression of UDP-glucuronosyltransferase 1A splicing variants was associated with DNA methylation status of individual first exons. CONCLUSIONS: Some DME genes were regulated by DNA methylation, potentially resulting in inter- and intra-individual differences in drug metabolism. Analysis of DNA methylation landscape facilitated elucidation of the role of DNA methylation in the regulation of DME genes, such as mediator of inter-individual variability, guide for correct alternative splicing, and potential tumor-suppressor or housekeeper. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0136-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4587720
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45877202015-09-30 Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes Habano, Wataru Kawamura, Kohei Iizuka, Natsuki Terashima, Jun Sugai, Tamotsu Ozawa, Shogo Clin Epigenetics Research BACKGROUND: Drug metabolizing enzymes (DMEs) exhibit dramatic inter- and intra-individual variability in expression and activity. However, the mechanisms determining this variability have not been fully elucidated. The aim of this study was to evaluate the biological significance of DNA methylation in the regulation of DME genes by genome-wide integrative analysis. RESULTS: DNA methylation and mRNA expression profiles of human tissues and hepatoma cells were examined by microarrays. The data were combined with GEO datasets of liver tissues, and integrative analysis was performed on selected DME genes. Detailed DNA methylation statuses at individual CpG sites were evaluated by DNA methylation mapping. From analysis of 20 liver tissues, highly variable DNA methylation was observed in 37 DME genes, 7 of which showed significant inverse correlations between DNA methylation and mRNA expression. In hepatoma cells, treatment with a demethylating agent resulted in upregulation of 5 DME genes, which could be explained by DNA methylation status. Interestingly, some DMEs were suggested to act as tumor-suppressor or housekeeper based on their unique DNA methylation features. Moreover, tissue-specific and age-dependent expression of UDP-glucuronosyltransferase 1A splicing variants was associated with DNA methylation status of individual first exons. CONCLUSIONS: Some DME genes were regulated by DNA methylation, potentially resulting in inter- and intra-individual differences in drug metabolism. Analysis of DNA methylation landscape facilitated elucidation of the role of DNA methylation in the regulation of DME genes, such as mediator of inter-individual variability, guide for correct alternative splicing, and potential tumor-suppressor or housekeeper. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0136-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-28 /pmc/articles/PMC4587720/ /pubmed/26421064 http://dx.doi.org/10.1186/s13148-015-0136-7 Text en © Habano et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Habano, Wataru
Kawamura, Kohei
Iizuka, Natsuki
Terashima, Jun
Sugai, Tamotsu
Ozawa, Shogo
Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title_full Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title_fullStr Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title_full_unstemmed Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title_short Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes
title_sort analysis of dna methylation landscape reveals the roles of dna methylation in the regulation of drug metabolizing enzymes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587720/
https://www.ncbi.nlm.nih.gov/pubmed/26421064
http://dx.doi.org/10.1186/s13148-015-0136-7
work_keys_str_mv AT habanowataru analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes
AT kawamurakohei analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes
AT iizukanatsuki analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes
AT terashimajun analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes
AT sugaitamotsu analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes
AT ozawashogo analysisofdnamethylationlandscaperevealstherolesofdnamethylationintheregulationofdrugmetabolizingenzymes